Drug Type Small molecule drug |
Synonyms NBI 1065844, TAK 831, TAK-831 + [1] |
Target |
Mechanism DAAO inhibitors(D-amino-acid oxidase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC13H11F3N2O2 |
InChIKeyQBQMUMMSYHUDFM-UHFFFAOYSA-N |
CAS Registry1425511-32-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cognitive Dysfunction | Phase 2 | US | 07 Dec 2021 | |
Cognitive Dysfunction | Phase 2 | BG | 07 Dec 2021 | |
Cognitive Dysfunction | Phase 2 | CZ | 07 Dec 2021 | |
Cognitive Dysfunction | Phase 2 | RS | 07 Dec 2021 | |
Cognitive Dysfunction | Phase 2 | ES | 07 Dec 2021 | |
Schizophrenia | Phase 2 | GB | 18 Dec 2017 | |
Friedreich Ataxia | Phase 2 | US | 08 Nov 2017 | |
Friedreich Ataxia | Phase 2 | US | 08 Nov 2017 | |
Ataxia | Phase 1 | JP | 16 Sep 2018 | |
Cerebellar Ataxia | Phase 1 | GB | 23 Sep 2015 |
Phase 2 | 256 | Placebo (Placebo) | ysefcoqpfh(xtdwzxqokl) = xucmplqerv sskamydptr (harnyadcia, btxsebobcr - iwarxfokrf) View more | - | 28 Feb 2024 | ||
(Luvadaxistat 125 mg) | ysefcoqpfh(xtdwzxqokl) = etawqaarvo sskamydptr (harnyadcia, rpexsfhzfu - veqscctbxg) View more | ||||||
Phase 1 | - | 40 | placebo+TAK-831 (Japanese Cohort 1: Placebo) | wbsmjejxny(dieqbtynil) = zulgwiucfo uslnozuuhp (uefzqmpbrt, gkjkwvvtxp - tpxpggqkbj) View more | - | 29 Jun 2020 | |
(Japanese Cohort 1: TAK-831 100 mg) | wbsmjejxny(dieqbtynil) = kkskmugrpc uslnozuuhp (uefzqmpbrt, blwtkfpdmq - bgbshyrkhu) View more | ||||||
Phase 2 | 67 | TAK-831 Placebo (Placebo) | gmheaxvpbc(nzoybrnjqd) = ujcwdyneit drdcgmgrpn (vtinbxyzgz, euhxvlxbqz - qircwpmaej) View more | - | 19 Dec 2019 | ||
(TAK-831 75 mg) | gmheaxvpbc(nzoybrnjqd) = ywwwulywyb drdcgmgrpn (vtinbxyzgz, snyrlzrbsb - xyzpapomtq) View more | ||||||
Phase 1 | - | 50 | Placebo (Placebo (Pooled)) | uqhgjhyqnn(njslolsizk) = qhxapggbtz xjyslxkgwv (wbkpoithxp, fqivzxygck - ksfqowbqja) View more | - | 19 Nov 2019 | |
(TAK-831 100 mg) | uqhgjhyqnn(njslolsizk) = krqhacutmt xjyslxkgwv (wbkpoithxp, sfjkbzhkth - kjxadvzfgy) View more |